CoSara starts TB clinical trials in India using Co-Diagnostics PCR tech
Go back to CoSara starts TB clinical trials in India using Co-Diagnostics PCR tech| (NASDAQ: CODX) | Delayed: 0.94 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.94 | 52 Week High | $ | |||
| Open | $0.98 | 52 Week Low | $ | |||
| Day High | $0.98 | P/E | N/A | |||
| Day Low | $0.94 | EPS | $ | |||
| Volume | 270,858 | |||||

